(VIANEWS) – The AICapitalize Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.
We, at Via News, will follow this AI algorithm and publish the results every week day.
Yesterday’s AI prediction for today would produce a ROI of -0.06% if an investor was to invest following yesterday’s AICapitalize AI suggestion.
See the data in the table below.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| eBay (EBAY) | 89.25% | $45.7 | 7.26% ✅ |
| CRH PLC (CRH) | 92.88% | $80.7 | 1.08% ✅ |
| Kellogg Company (K) | 89.14% | $57.02 | 0.99% ✅ |
| Abbott Laboratories (ABT) | 94.19% | $121.65 | 0.82% ✅ |
| Toll Brothers (TOL) | 94.14% | $114.36 | 0.71% ✅ |
| JP Morgan Chase (JPM) | 88.93% | $187.73 | 0.58% ✅ |
| Sherwin (SHW) | 93.17% | $334.77 | 0.56% ✅ |
| Trip.com (TCOM) | 93.06% | $45 | 0.54% ✅ |
| Procter & Gamble (PG) | 88.57% | $163.07 | 0.43% ✅ |
| Darden Restaurants (DRI) | 93.75% | $173.86 | 0.38% ✅ |
| HSBC (HSBC) | 88.89% | $38.71 | 0.31% ✅ |
| Comcast Corporation (CMCSA) | 88.91% | $43.24 | 0.19% ✅ |
| Orix Corp (IX) | 94.7% | $106.29 | 0.14% ✅ |
| Marriott International (MAR) | 92.99% | $255.1 | 0.08% ✅ |
| Air Products and Chemicals (APD) | 89.01% | $241.76 | 0.02% ✅ |
| GlaxoSmithKline (GSK) | 88.52% | $42.97 | -0.05% |
| Citizens Financial Group (CFG) | 89.19% | $30.87 | -0.07% |
| Hormel Foods (HRL) | 89.06% | $31.85 | -0.29% |
| Baxter International (BAX) | 89.31% | $42.27 | -0.43% |
| NewMarket (NEU) | 88.96% | $657.91 | -0.48% |
| Regeneron Pharmaceuticals (REGN) | 88.6% | $1025.52 | -0.48% |
| Novartis AG (NVS) | 88.94% | $104.93 | -0.86% |
| Tenet Healthcare (THC) | 88.99% | $91.26 | -1.13% |
| Astrazeneca (AZN) | 93.75% | $67.77 | -1.48% |
| America Movil (AMX) | 98.73% | $19.47 | -2.12% |
| argenx SE (ARGX) | 94.57% | $415.67 | -3.59% |
| Genmab (GMAB) | 98.51% | $29.96 | -4.88% |
1. eBay (EBAY)
eBay has been having an accuracy rate of 89.25% over the last 10 sessions. Previous close price was $44.65 the AI prediction was $45.7 and today’s closing price was $47.89. The intraday ROI for eBay (EBAY) was 7.26%.
Shares of eBay jumped by a staggering 13.85% in from $42.01 to $47.83 at 21:29 EST on Wednesday, after two consecutive sessions in a row of gains. NASDAQ is sliding 0.55% to $15,947.74, following the last session’s downward trend.
eBay Inc. operates marketplace platforms that connect buyers and sellers in the United States and internationally.
Earnings Per Share
As for profitability, eBay has a trailing twelve months EPS of $4.98.
PE Ratio
eBay has a trailing twelve months price to earnings ratio of 9.6. Meaning, the purchaser of the share is investing $9.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.56%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
eBay’s EBITDA is 13.93.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, eBay’s stock is considered to be oversold (<=20).
Previous days news about eBay
- Ebay (ebay) reports Q4 earnings: what key metrics have to say. According to Zacks on Tuesday, 27 February, "Here is how eBay performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about eBay.
2. CRH PLC (CRH)
CRH PLC has been having an accuracy rate of 92.88% over the last 10 sessions. Previous close price was $78.47 the AI prediction was $80.7 and today’s closing price was $79.32. The intraday ROI for CRH PLC (CRH) was 1.08%.
Shares of CRH PLC jumped 9.14% in from $72.39 to $79.01 at 21:29 EST on Wednesday, following the last session’s upward trend. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
CRH plc, through its subsidiaries, manufactures and distributes building materials in Ireland and internationally.
Earnings Per Share
As for profitability, CRH PLC has a trailing twelve months EPS of $3.85.
PE Ratio
CRH PLC has a trailing twelve months price to earnings ratio of 20.52. Meaning, the purchaser of the share is investing $20.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.67%.
Volume
Today’s last reported volume for CRH PLC is 4709200 which is 30.29% above its average volume of 3614320.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Dec 14, 2023, the estimated forward annual dividend rate is 1.33 and the estimated forward annual dividend yield is 1.68%.
Volatility
CRH PLC’s last week, last month’s, and last quarter’s current intraday variation average was 0.09%, 0.59%, and 1.12%.
CRH PLC’s highest amplitude of average volatility was 0.98% (last week), 1.16% (last month), and 1.12% (last quarter).
More news about CRH PLC.
3. Kellogg Company (K)
Kellogg Company has been having an accuracy rate of 89.14% over the last 10 sessions. Previous close price was $55.56 the AI prediction was $57.02 and today’s closing price was $56.11. The intraday ROI for Kellogg Company (K) was 0.99%.
Shares of Kellogg Company rose 1.41% in from $55.21 to $55.99 at 21:29 EST on Wednesday, after two consecutive sessions in a row of gains. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
Kellanova, together with its subsidiaries, manufactures and markets snacks and convenience foods in North America, Europe, Latin America, the Asia Pacific, the Middle East, Australia, and Africa.
Earnings Per Share
As for profitability, Kellogg Company has a trailing twelve months EPS of $2.25.
PE Ratio
Kellogg Company has a trailing twelve months price to earnings ratio of 24.88. Meaning, the purchaser of the share is investing $24.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.35%.
More news about Kellogg Company.
4. Abbott Laboratories (ABT)
Abbott Laboratories has been having an accuracy rate of 94.19% over the last 10 sessions. Previous close price was $119.07 the AI prediction was $121.65 and today’s closing price was $120.05. The intraday ROI for Abbott Laboratories (ABT) was 0.82%.
Shares of Abbott Laboratories rose 5.64% in from $113.42 to $119.82 at 21:29 EST on Wednesday, after two sequential sessions in a row of gains. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Earnings Per Share
As for profitability, Abbott Laboratories has a trailing twelve months EPS of $3.26.
PE Ratio
Abbott Laboratories has a trailing twelve months price to earnings ratio of 36.76. Meaning, the purchaser of the share is investing $36.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.11%.
More news about Abbott Laboratories.
5. Toll Brothers (TOL)
Toll Brothers has been having an accuracy rate of 94.14% over the last 10 sessions. Previous close price was $111.38 the AI prediction was $114.36 and today’s closing price was $112.17. The intraday ROI for Toll Brothers (TOL) was 0.71%.
Shares of Toll Brothers rose by a staggering 12.01% in from $100.1 to $112.12 at 21:29 EST on Wednesday, following the last session’s upward trend. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
Toll Brothers, Inc., together with its subsidiaries, designs, builds, markets, sells, and arranges finance for a range of detached and attached homes in luxury residential communities in the United States.
Earnings Per Share
As for profitability, Toll Brothers has a trailing twelve months EPS of $12.91.
PE Ratio
Toll Brothers has a trailing twelve months price to earnings ratio of 8.68. Meaning, the purchaser of the share is investing $8.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.38%.
Moving Average
Toll Brothers’s value is way higher than its 50-day moving average of $93.71 and way above its 200-day moving average of $78.16.
Volume
Today’s last reported volume for Toll Brothers is 827367 which is 47.33% below its average volume of 1571080.
Revenue Growth
Year-on-year quarterly revenue growth declined by 18.6%, now sitting on 9.99B for the twelve trailing months.
Volatility
Toll Brothers’s last week, last month’s, and last quarter’s current intraday variation average was 0.45%, 0.47%, and 1.61%.
Toll Brothers’s highest amplitude of average volatility was 1.19% (last week), 1.64% (last month), and 1.61% (last quarter).
More news about Toll Brothers.
6. JP Morgan Chase (JPM)
JP Morgan Chase has been having an accuracy rate of 88.93% over the last 10 sessions. Previous close price was $183.32 the AI prediction was $187.73 and today’s closing price was $184.38. The intraday ROI for JP Morgan Chase (JPM) was 0.58%.
Shares of JP Morgan Chase rose 4.47% in from $176.25 to $184.13 at 21:29 EST on Wednesday, after two consecutive sessions in a row of gains. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
JPMorgan Chase & Co. operates as a financial services company worldwide.
Earnings Per Share
As for profitability, JP Morgan Chase has a trailing twelve months EPS of $16.24.
PE Ratio
JP Morgan Chase has a trailing twelve months price to earnings ratio of 11.34. Meaning, the purchaser of the share is investing $11.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.98%.
Moving Average
JP Morgan Chase’s value is higher than its 50-day moving average of $171.84 and way above its 200-day moving average of $152.81.
Yearly Top and Bottom Value
JP Morgan Chase’s stock is valued at $184.13 at 21:29 EST, under its 52-week high of $185.20 and way higher than its 52-week low of $123.11.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, JP Morgan Chase’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for JP Morgan Chase is 4698700 which is 50.09% below its average volume of 9415580.
More news about JP Morgan Chase.
7. Sherwin (SHW)
Sherwin has been having an accuracy rate of 93.17% over the last 10 sessions. Previous close price was $327.83 the AI prediction was $334.77 and today’s closing price was $329.68. The intraday ROI for Sherwin (SHW) was 0.56%.
Shares of Sherwin rose 7.28% in from $307.2 to $329.56 at 21:29 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is dropping 0.14% to $17,573.69, following the last session’s downward trend.
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers.
Earnings Per Share
As for profitability, Sherwin has a trailing twelve months EPS of $9.24.
PE Ratio
Sherwin has a trailing twelve months price to earnings ratio of 35.67. Meaning, the purchaser of the share is investing $35.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 75.85%.
More news about Sherwin.
8. Trip.com (TCOM)
Trip.com has been having an accuracy rate of 93.06% over the last 10 sessions. Previous close price was $44.22 the AI prediction was $45 and today’s closing price was $44.46. The intraday ROI for Trip.com (TCOM) was 0.54%.
Shares of Trip.com jumped by a staggering 22.6% in from $36.19 to $44.37 at 21:29 EST on Wednesday, following the last session’s upward trend. NASDAQ is dropping 0.55% to $15,947.74, following the last session’s downward trend.
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $2.08.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 21.33. Meaning, the purchaser of the share is investing $21.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.48%.
More news about Trip.com.
9. Procter & Gamble (PG)
Procter & Gamble has been having an accuracy rate of 88.57% over the last 10 sessions. Previous close price was $159.36 the AI prediction was $163.07 and today’s closing price was $160.05. The intraday ROI for Procter & Gamble (PG) was 0.43%.
Shares of Procter & Gamble jumped 1.57% in from $157.58 to $160.05 at 21:29 EST on Wednesday, following the last session’s upward trend. NYSE is dropping 0.14% to $17,573.69, following the last session’s downward trend.
The Procter & Gamble Company provides branded consumer packaged goods worldwide.
Earnings Per Share
As for profitability, Procter & Gamble has a trailing twelve months EPS of $5.97.
PE Ratio
Procter & Gamble has a trailing twelve months price to earnings ratio of 26.81. Meaning, the purchaser of the share is investing $26.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.78%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 4.4% and a negative 6.6%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Procter & Gamble’s stock is considered to be overbought (>=80).
Sales Growth
Procter & Gamble’s sales growth for the next quarter is negative 5.8%.
More news about Procter & Gamble.
10. Darden Restaurants (DRI)
Darden Restaurants has been having an accuracy rate of 93.75% over the last 10 sessions. Previous close price was $169.8 the AI prediction was $173.86 and today’s closing price was $170.45. The intraday ROI for Darden Restaurants (DRI) was 0.38%.
Shares of Darden Restaurants jumped 3.61% in from $163.8 to $169.71 at 21:29 EST on Wednesday, following the last session’s upward trend. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
Darden Restaurants, Inc., together with its subsidiaries, owns and operates full-service restaurants in the United States and Canada.
Earnings Per Share
As for profitability, Darden Restaurants has a trailing twelve months EPS of $8.26.
PE Ratio
Darden Restaurants has a trailing twelve months price to earnings ratio of 20.55. Meaning, the purchaser of the share is investing $20.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.72%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.7%, now sitting on 11.01B for the twelve trailing months.
Yearly Top and Bottom Value
Darden Restaurants’s stock is valued at $169.71 at 21:29 EST, below its 52-week high of $173.06 and way higher than its 52-week low of $133.36.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 12.8% and 1.6%, respectively.
More news about Darden Restaurants.
11. HSBC (HSBC)
HSBC has been having an accuracy rate of 88.89% over the last 10 sessions. Previous close price was $38.37 the AI prediction was $38.71 and today’s closing price was $38.49. The intraday ROI for HSBC (HSBC) was 0.31%.
Shares of HSBC dropped 3.72% in from $39.88 to $38.40 at 21:29 EST on Wednesday, after four consecutive sessions in a row of gains. NYSE is dropping 0.14% to $17,573.69, following the last session’s downward trend.
HSBC Holdings plc provides banking and financial services worldwide.
Earnings Per Share
As for profitability, HSBC has a trailing twelve months EPS of $5.7.
PE Ratio
HSBC has a trailing twelve months price to earnings ratio of 6.74. Meaning, the purchaser of the share is investing $6.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.65%.
Volatility
HSBC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.57%, a negative 0.19%, and a positive 1.10%.
HSBC’s highest amplitude of average volatility was 0.79% (last week), 1.34% (last month), and 1.10% (last quarter).
Yearly Top and Bottom Value
HSBC’s stock is valued at $38.40 at 21:29 EST, under its 52-week high of $42.47 and way above its 52-week low of $32.41.
More news about HSBC.
12. Comcast Corporation (CMCSA)
Comcast Corporation has been having an accuracy rate of 88.91% over the last 10 sessions. Previous close price was $42.07 the AI prediction was $43.24 and today’s closing price was $42.15. The intraday ROI for Comcast Corporation (CMCSA) was 0.19%.
Shares of Comcast Corporation fell by a staggering 10.55% in from $47.24 to $42.26 at 21:29 EST on Wednesday, following the last session’s downward trend. NASDAQ is sliding 0.55% to $15,947.74, following the last session’s downward trend.
Comcast Corporation operates as a media and technology company worldwide.
Earnings Per Share
As for profitability, Comcast Corporation has a trailing twelve months EPS of $3.71.
PE Ratio
Comcast Corporation has a trailing twelve months price to earnings ratio of 11.39. Meaning, the purchaser of the share is investing $11.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.25%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 2, 2024, the estimated forward annual dividend rate is 1.24 and the estimated forward annual dividend yield is 2.96%.
Sales Growth
Comcast Corporation’s sales growth is negative 5.7% for the ongoing quarter and negative 6.5% for the next.
Volume
Today’s last reported volume for Comcast Corporation is 7356320 which is 62.66% below its average volume of 19703400.
More news about Comcast Corporation.
13. Orix Corp (IX)
Orix Corp has been having an accuracy rate of 94.7% over the last 10 sessions. Previous close price was $104.94 the AI prediction was $106.29 and today’s closing price was $105.09. The intraday ROI for Orix Corp (IX) was 0.14%.
Shares of Orix Corp jumped 8.79% in from $96.29 to $104.75 at 21:29 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
ORIX Corporation provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
Earnings Per Share
As for profitability, Orix Corp has a trailing twelve months EPS of $7.99.
PE Ratio
Orix Corp has a trailing twelve months price to earnings ratio of 13.11. Meaning, the purchaser of the share is investing $13.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.82%.
More news about Orix Corp.
14. Marriott International (MAR)
Marriott International has been having an accuracy rate of 92.99% over the last 10 sessions. Previous close price was $248.78 the AI prediction was $255.1 and today’s closing price was $248.99. The intraday ROI for Marriott International (MAR) was 0.08%.
Shares of Marriott International rose 2.02% in from $243.49 to $248.41 at 21:29 EST on Wednesday, after three successive sessions in a row of losses. NASDAQ is falling 0.55% to $15,947.74, following the last session’s downward trend.
Marriott International, Inc. engages in operating, franchising, and licensing hotel, residential, timeshare, and other lodging properties worldwide.
Earnings Per Share
As for profitability, Marriott International has a trailing twelve months EPS of $10.19.
PE Ratio
Marriott International has a trailing twelve months price to earnings ratio of 24.38. Meaning, the purchaser of the share is investing $24.38 for every dollar of annual earnings.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Marriott International’s EBITDA is 3.59.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marriott International’s stock is considered to be overbought (>=80).
Moving Average
Marriott International’s worth is above its 50-day moving average of $232.96 and way above its 200-day moving average of $202.83.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 6.3B for the twelve trailing months.
More news about Marriott International.
15. Air Products and Chemicals (APD)
Air Products and Chemicals has been having an accuracy rate of 89.01% over the last 10 sessions. Previous close price was $232.36 the AI prediction was $241.76 and today’s closing price was $232.41. The intraday ROI for Air Products and Chemicals (APD) was 0.02%.
Shares of Air Products and Chemicals slid by a staggering 11.98% in from $263.77 to $232.17 at 21:29 EST on Wednesday, after two successive sessions in a row of gains. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally.
Earnings Per Share
As for profitability, Air Products and Chemicals has a trailing twelve months EPS of $10.45.
PE Ratio
Air Products and Chemicals has a trailing twelve months price to earnings ratio of 22.22. Meaning, the purchaser of the share is investing $22.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.46%.
More news about Air Products and Chemicals.
16. GlaxoSmithKline (GSK)
GlaxoSmithKline has been having an accuracy rate of 88.52% over the last 10 sessions. Previous close price was $42.36 the AI prediction was $42.97 and today’s closing price was $42.34. The intraday ROI for GlaxoSmithKline (GSK) was -0.05%.
Shares of GlaxoSmithKline rose 8.29% in from $39.09 to $42.33 at 21:29 EST on Wednesday, following the last session’s downward trend. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $3.04.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 13.93. Meaning, the purchaser of the share is investing $13.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.38%.
Volume
Today’s last reported volume for GlaxoSmithKline is 3717860 which is 3.97% above its average volume of 3575670.
Sales Growth
GlaxoSmithKline’s sales growth is 9.7% for the present quarter and 6.2% for the next.
Yearly Top and Bottom Value
GlaxoSmithKline’s stock is valued at $42.33 at 21:29 EST, below its 52-week high of $42.61 and way higher than its 52-week low of $33.20.
More news about GlaxoSmithKline.
17. Citizens Financial Group (CFG)
Citizens Financial Group has been having an accuracy rate of 89.19% over the last 10 sessions. Previous close price was $30.76 the AI prediction was $30.87 and today’s closing price was $30.74. The intraday ROI for Citizens Financial Group (CFG) was -0.07%.
Shares of Citizens Financial Group slid by a staggering 11.35% in from $34.8 to $30.85 at 21:29 EST on Wednesday, after two sequential sessions in a row of losses. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
Citizens Financial Group, Inc. operates as the bank holding company that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, corporations, and institutions in the United States.
Earnings Per Share
As for profitability, Citizens Financial Group has a trailing twelve months EPS of $3.13.
PE Ratio
Citizens Financial Group has a trailing twelve months price to earnings ratio of 9.86. Meaning, the purchaser of the share is investing $9.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.7%.
Moving Average
Citizens Financial Group’s worth is below its 50-day moving average of $32.42 and above its 200-day moving average of $28.59.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 25% and a negative 16.3%, respectively.
Volume
Today’s last reported volume for Citizens Financial Group is 1466050 which is 74.67% below its average volume of 5787860.
More news about Citizens Financial Group.
18. Hormel Foods (HRL)
Hormel Foods has been having an accuracy rate of 89.06% over the last 10 sessions. Previous close price was $30.92 the AI prediction was $31.85 and today’s closing price was $30.83. The intraday ROI for Hormel Foods (HRL) was -0.29%.
Shares of Hormel Foods jumped 0.29% in from $30.68 to $30.77 at 21:29 EST on Wednesday, after two consecutive sessions in a row of losses. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and other food products to retail, foodservice, deli, and commercial customers in the United States and internationally.
Earnings Per Share
As for profitability, Hormel Foods has a trailing twelve months EPS of $1.45.
PE Ratio
Hormel Foods has a trailing twelve months price to earnings ratio of 21.22. Meaning, the purchaser of the share is investing $21.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.38%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 15% and a negative 7.5%, respectively.
More news about Hormel Foods.
19. Baxter International (BAX)
Baxter International has been having an accuracy rate of 89.31% over the last 10 sessions. Previous close price was $41.74 the AI prediction was $42.27 and today’s closing price was $41.56. The intraday ROI for Baxter International (BAX) was -0.43%.
Shares of Baxter International rose 7% in from $38.71 to $41.42 at 21:29 EST on Wednesday, after three consecutive sessions in a row of losses. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
Earnings Per Share
As for profitability, Baxter International has a trailing twelve months EPS of $-0.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Baxter International’s EBITDA is 2.21.
Sales Growth
Baxter International’s sales growth is negative 1.4% for the ongoing quarter and 1.7% for the next.
Yearly Top and Bottom Value
Baxter International’s stock is valued at $41.42 at 21:29 EST, way under its 52-week high of $50.21 and way higher than its 52-week low of $31.01.
More news about Baxter International.
20. NewMarket (NEU)
NewMarket has been having an accuracy rate of 88.96% over the last 10 sessions. Previous close price was $636.66 the AI prediction was $657.91 and today’s closing price was $633.63. The intraday ROI for NewMarket (NEU) was -0.48%.
Shares of NewMarket rose by a staggering 11.76% in from $566.45 to $633.06 at 21:29 EST on Wednesday, following the last session’s downward trend. NYSE is dropping 0.14% to $17,573.69, following the last session’s downward trend.
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives.
Earnings Per Share
As for profitability, NewMarket has a trailing twelve months EPS of $40.47.
PE Ratio
NewMarket has a trailing twelve months price to earnings ratio of 15.64. Meaning, the purchaser of the share is investing $15.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.28%.
Moving Average
NewMarket’s worth is way above its 50-day moving average of $574.16 and way above its 200-day moving average of $481.98.
Volume
Today’s last reported volume for NewMarket is 27284 which is 44.04% below its average volume of 48757.
Sales Growth
NewMarket’s sales growth for the next quarter is 2.9%.
More news about NewMarket.
21. Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals has been having an accuracy rate of 88.6% over the last 10 sessions. Previous close price was $992.36 the AI prediction was $1025.52 and today’s closing price was $987.61. The intraday ROI for Regeneron Pharmaceuticals (REGN) was -0.48%.
Shares of Regeneron Pharmaceuticals rose 3.5% in from $957.64 to $991.16 at 21:29 EST on Wednesday, following the last session’s downward trend. NASDAQ is falling 0.55% to $15,947.74, following the last session’s downward trend.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Earnings Per Share
As for profitability, Regeneron Pharmaceuticals has a trailing twelve months EPS of $34.8.
PE Ratio
Regeneron Pharmaceuticals has a trailing twelve months price to earnings ratio of 28.48. Meaning, the purchaser of the share is investing $28.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.26%.
More news about Regeneron Pharmaceuticals.
22. Novartis AG (NVS)
Novartis AG has been having an accuracy rate of 88.94% over the last 10 sessions. Previous close price was $103.11 the AI prediction was $104.93 and today’s closing price was $102.22. The intraday ROI for Novartis AG (NVS) was -0.86%.
Shares of Novartis AG fell 5.43% in from $108.13 to $102.26 at 21:29 EST on Wednesday, after three successive sessions in a row of losses. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $4.1.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 24.94. Meaning, the purchaser of the share is investing $24.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.15%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 2.9% and 1.6%, respectively.
Moving Average
Novartis AG’s value is under its 50-day moving average of $103.19 and above its 200-day moving average of $100.31.
Volatility
Novartis AG’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.11%, a negative 0.23%, and a positive 0.78%.
Novartis AG’s highest amplitude of average volatility was 0.60% (last week), 0.90% (last month), and 0.78% (last quarter).
Volume
Today’s last reported volume for Novartis AG is 1983910 which is 35.12% above its average volume of 1468180.
More news about Novartis AG.
23. Tenet Healthcare (THC)
Tenet Healthcare has been having an accuracy rate of 88.99% over the last 10 sessions. Previous close price was $90.24 the AI prediction was $91.26 and today’s closing price was $89.22. The intraday ROI for Tenet Healthcare (THC) was -1.13%.
Shares of Tenet Healthcare rose 7.71% in from $82.83 to $89.22 at 21:29 EST on Wednesday, after three consecutive sessions in a row of losses. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
Earnings Per Share
As for profitability, Tenet Healthcare has a trailing twelve months EPS of $5.71.
PE Ratio
Tenet Healthcare has a trailing twelve months price to earnings ratio of 15.63. Meaning, the purchaser of the share is investing $15.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.15%.
Yearly Top and Bottom Value
Tenet Healthcare’s stock is valued at $89.22 at 21:29 EST, higher than its 52-week high of $85.40.
Volume
Today’s last reported volume for Tenet Healthcare is 1029800 which is 3.57% below its average volume of 1068030.
More news about Tenet Healthcare.
24. Astrazeneca (AZN)
Astrazeneca has been having an accuracy rate of 93.75% over the last 10 sessions. Previous close price was $66.33 the AI prediction was $67.77 and today’s closing price was $65.35. The intraday ROI for Astrazeneca (AZN) was -1.48%.
Shares of Astrazeneca fell 2.98% in from $67.37 to $65.36 at 21:29 EST on Wednesday, following the last session’s downward trend. NYSE is sliding 0.14% to $17,573.69, following the last session’s downward trend.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.9.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 34.4. Meaning, the purchaser of the share is investing $34.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.64%.
Yearly Top and Bottom Value
Astrazeneca’s stock is valued at $65.36 at 21:29 EST, way below its 52-week high of $76.56 and above its 52-week low of $60.47.
Moving Average
Astrazeneca’s worth is below its 50-day moving average of $66.21 and below its 200-day moving average of $67.83.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 45.81B for the twelve trailing months.
More news about Astrazeneca.
25. America Movil (AMX)
America Movil has been having an accuracy rate of 98.73% over the last 10 sessions. Previous close price was $19.33 the AI prediction was $19.47 and today’s closing price was $18.92. The intraday ROI for America Movil (AMX) was -2.12%.
Shares of America Movil jumped 4.36% in from $18.14 to $18.93 at 21:29 EST on Wednesday, following the last session’s downward trend. NYSE is falling 0.14% to $17,573.69, following the last session’s downward trend.
América Móvil, S.A.B. de C.V. provides telecommunications services in Latin America and internationally.
Earnings Per Share
As for profitability, America Movil has a trailing twelve months EPS of $1.42.
PE Ratio
America Movil has a trailing twelve months price to earnings ratio of 13.33. Meaning, the purchaser of the share is investing $13.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.8%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, America Movil’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for America Movil is 1117730 which is 26.89% below its average volume of 1528940.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 9, 2023, the estimated forward annual dividend rate is 0.53 and the estimated forward annual dividend yield is 2.77%.
More news about America Movil.
26. argenx SE (ARGX)
argenx SE has been having an accuracy rate of 94.57% over the last 10 sessions. Previous close price was $412.51 the AI prediction was $415.67 and today’s closing price was $397.7. The intraday ROI for argenx SE (ARGX) was -3.59%.
Shares of argenx SE jumped 4.48% in from $380.78 to $397.84 at 21:29 EST on Wednesday, following the last session’s downward trend. NASDAQ is falling 0.55% to $15,947.74, following the last session’s downward trend.
argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy.
Earnings Per Share
As for profitability, argenx SE has a trailing twelve months EPS of $-4.11.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, argenx SE’s stock is considered to be oversold (<=20).
More news about argenx SE.
27. Genmab (GMAB)
Genmab has been having an accuracy rate of 98.51% over the last 10 sessions. Previous close price was $29.09 the AI prediction was $29.96 and today’s closing price was $27.67. The intraday ROI for Genmab (GMAB) was -4.88%.
Shares of Genmab fell 1.88% in from $28.2 to $27.67 at 21:29 EST on Wednesday, after two consecutive sessions in a row of losses. NASDAQ is falling 0.55% to $15,947.74, following the last session’s downward trend.
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $0.96.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 28.82. Meaning, the purchaser of the share is investing $28.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.78%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Genmab’s stock is considered to be overbought (>=80).
Moving Average
Genmab’s worth is below its 50-day moving average of $29.71 and way under its 200-day moving average of $34.61.
More news about Genmab.
